These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 30204440)

  • 1. An Analysis of Different Components of a High-Throughput Screening Library.
    Saha A; Varghese T; Liu A; Allen SJ; Mirzadegan T; Hack MD
    J Chem Inf Model; 2018 Oct; 58(10):2057-2068. PubMed ID: 30204440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule Library Subset Screening as an Aid for Accelerating Lead Identification.
    Beresini MH; Liu Y; Dawes TD; Clark KR; Orren L; Schmidt S; Turincio R; Jones SW; Rodriguez RA; Thana P; Hascall D; Gross DP; Skelton NJ
    J Biomol Screen; 2014 Jun; 19(5):758-70. PubMed ID: 24518067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
    Roy A; McDonald PR; Sittampalam S; Chaguturu R
    Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient hit-finding approaches for histone methyltransferases: the key parameters.
    Ahrens T; Bergner A; Sheppard D; Hafenbradl D
    J Biomol Screen; 2012 Jan; 17(1):85-98. PubMed ID: 21990582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
    Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
    SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Industrial medicinal chemistry insights: neuroscience hit generation at Janssen.
    Tresadern G; Rombouts FJR; Oehlrich D; Macdonald G; Trabanco AA
    Drug Discov Today; 2017 Oct; 22(10):1478-1488. PubMed ID: 28669605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
    Paricharak S; Méndez-Lucio O; Chavan Ravindranath A; Bender A; IJzerman AP; van Westen GJP
    Brief Bioinform; 2018 Mar; 19(2):277-285. PubMed ID: 27789427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the delivery of next generation therapeutics from high throughput screening libraries.
    Wigglesworth MJ; Murray DC; Blackett CJ; Kossenjans M; Nissink JW
    Curr Opin Chem Biol; 2015 Jun; 26():104-10. PubMed ID: 25909818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Lead Factory: An updated HTS compound library for innovative drug discovery.
    van Vlijmen H; Ortholand JY; Li VM; de Vlieger JSB
    Drug Discov Today; 2021 Oct; 26(10):2406-2413. PubMed ID: 33892142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach towards enhancement of a screening library: The Next Generation Library Initiative (NGLI) at Bayer - against all odds?
    Follmann M; Briem H; Steinmeyer A; Hillisch A; Schmitt MH; Haning H; Meier H
    Drug Discov Today; 2019 Mar; 24(3):668-672. PubMed ID: 30562586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Locating sweet spots for screening hits and evaluating pan-assay interference filters from the performance analysis of two lead-like libraries.
    Mok NY; Maxe S; Brenk R
    J Chem Inf Model; 2013 Mar; 53(3):534-44. PubMed ID: 23451880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening Library Design.
    Ashenden SK
    Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Novartis' Small Molecule Screening Deck Design.
    Schuffenhauer A; Schneider N; Hintermann S; Auld D; Blank J; Cotesta S; Engeloch C; Fechner N; Gaul C; Giovannoni J; Jansen J; Joslin J; Krastel P; Lounkine E; Manchester J; Monovich LG; Pelliccioli AP; Schwarze M; Shultz MD; Stiefl N; Baeschlin DK
    J Med Chem; 2020 Dec; 63(23):14425-14447. PubMed ID: 33140646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
    Lee OW; Austin S; Gamma M; Cheff DM; Lee TD; Wilson KM; Johnson J; Travers J; Braisted JC; Guha R; Klumpp-Thomas C; Shen M; Hall MD
    SLAS Discov; 2020 Jan; 25(1):9-20. PubMed ID: 31498718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plate-based diversity subset screening generation 2: an improved paradigm for high-throughput screening of large compound files.
    Bell AS; Bradley J; Everett JR; Loesel J; McLoughlin D; Mills J; Peakman MC; Sharp RE; Williams C; Zhu H
    Mol Divers; 2016 Nov; 20(4):789-803. PubMed ID: 27631533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.
    Kauler KR; Hevener KE
    Methods Mol Biol; 2025; 2834():181-193. PubMed ID: 39312166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational methods for the selection of diverse screening compounds.
    Huggins DJ; Venkitaraman AR; Spring DR
    ACS Chem Biol; 2011 Mar; 6(3):208-17. PubMed ID: 21261294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent hits and where to find them.
    Lucas SCC; Blackwell JH; Hewitt SH; Semple H; Whitehurst BC; Xu H
    SLAS Discov; 2024 Apr; 29(3):100142. PubMed ID: 38278484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.